Education
About Us
Working with TipRanks
Follow Us
Arctic Bioscience AS (DE:9TD)
:9TD
9TD Stock Chart & Stats
€0.22
€0.02(14.65%)
At close: 4:00 PM EST
€0.22
€0.02(14.65%)
Day’s Range― - ―
52-Week Range€0.08 - €0.54
Previous CloseN/A
Volume0.00
Average Volume (3M)8.00
Market Cap
€8.50M
Enterprise ValueN/A
Total Cash (Recent Filing)€2.16M
Total Debt (Recent Filing)€32.86M
Price to Earnings (P/E)―
Beta0.33
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.17
Shares Outstanding26,859,340
10 Day Avg. Volume0
30 Day Avg. Volume8
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Arctic Bioscience AS News
9TD FAQ
What was Arctic Bioscience AS’s price range in the past 12 months?
Arctic Bioscience AS lowest stock price was €0.08 and its highest was €0.54 in the past 12 months.
What is Arctic Bioscience AS’s market cap?
Arctic Bioscience AS’s market cap is €8.50M.
When is Arctic Bioscience AS’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Arctic Bioscience AS’s earnings last quarter?
Currently, no data Available
Is Arctic Bioscience AS overvalued?
According to Wall Street analysts Arctic Bioscience AS’s price is currently Overvalued.
Does Arctic Bioscience AS pay dividends?
Arctic Bioscience AS does not currently pay dividends.
What is Arctic Bioscience AS’s EPS estimate?
Arctic Bioscience AS’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Arctic Bioscience AS have?
Arctic Bioscience AS has 26,859,340 shares outstanding.
What happened to Arctic Bioscience AS’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Arctic Bioscience AS?
Currently, no hedge funds are holding shares in DE:9TD
Company Description
Arctic Bioscience AS
Arctic Bioscience AS, a biotechnology company, develops and commercializes pharmaceutical and nutraceutical products. Its development stage product candidate is HRO350, a novel oral treatment for mild-to-moderate psoriasis. The company sells its nutraceuticals as bulk ingredients to other companies under the ROMEGA brand worldwide. Arctic Bioscience AS was incorporated in 2011 and is based in Ørsta, Norway.